menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    YourBio Health Strengthens Leadership Team for Growth

    PR NEWSWIRE

    Flagship forges Cambridge connection with UK research orgs

    FIERCE BIOTECH

    Flagship-backed Sonata lays off about 20 staffers as CEO departs

    FIERCE BIOTECH

    Pfizer, Flagship return to obesity as part of 10-program collab

    FIERCE BIOTECH

    Flagship Pioneering Announces Deals with Ampersand & Montai

    PR NEWSWIRE

    Flagship Pioneering Appoints Angela as CEO of Metaphore Biotech

    PR NEWSWIRE

    GSK Signs Parkinson’s Deal with Flagship’s Vesalius for $570M

    FIERCE BIOTECH

    Ring Therapeutics Announces A*STAR & SERI Partnerships in Singapore

    GLOBENEWSWIRE

    Ring Therapeutics To Present Keynote At SPICA Conference

    GLOBENEWSWIRE

    Flagship hopes biotechs flock to Mirai to boost genetic meds

    FIERCE BIOTECH

    Novartis inks $1B-plus biobucks deal with Flagship`s Generate

    BIOSPACE

    Pfizer Partners With Flagship’s Quotient to Leverage Genetics Against Heart

    BIOSPACE

    GSK becomes Flagship`s latest partner in $7B biobucks respiratory, immunology pact

    FIERCE BIOTECH

    Flagship raises $3.6B for biotech investing

    PRESS RELEASE

    Pfizer, Flagship name first target for $7B collab: obesity

    FIERCE BIOTECH

    Novo Nordisk ties up with Metaphore to develop new obesity drugs

    REUTERS

    Flagship Unveils Prologue For Viral Proteome Therapeutics

    BUSINESSWIRE

    Prologue, Flagship’s newest startup, looks to mine viruses for new drugs

    BIOPHARMADIVE

    Flagship CEO says firm has work to do before inking China pacts

    FIERCE BIOTECH

    Flagship-founded Axcella folds

    FIERCE BIOTECH

    Flagship opens hub, plants roots in the UK

    ENDPTS

    Flagship launches first UK biotech Quotient Therapeutics

    FIERCE BIOTECH

    Flagship Pioneering takes another big step across the globe

    ENDPTS

    Flagship merges its troubled circular RNA company Laronde

    ENDPTS

    Flagship recasts its corporate brand with ‘Bigger Leaps’ tagline and ambition

    ENDPTS

    Flagship poaches ex-GSK leader John Lepore

    FIERCE BIOTECH

    Flagship poaches another pharma R&D leader as GSK`s Lepore heads to ProFound

    ENDPTS

    Flagship Pioneering Announces Appointment of Amanda Kay as CBDO

    PR NEWSWIRE

    Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner

    PR NEWSWIRE

    Flagship Pioneering Appoints Jason Gardner as CEO-Partner

    PR NEWSWIRE

    Alltrna raises $109M for tRNA therapies that restore missing proteins

    ENDPTS

    Pfizer, Flagship Pioneering to invest $100 mln in drug discovery

    REUTERS

    Flagship snags former BMS R&D chief Vessey as chief scientist

    FIERCE BIOTECH

    Flagship-launched Empress shoots for 4 INDs over next 2 years

    FIERCE BIOTECH

    Flagship Pioneering Unveils Empress to Revolutionize Drug Discovery

    PR NEWSWIRE

    Flagship unveils Metaphore with $50M to mimic natural chemistry

    FIERCE BIOTECH

    Flagship biotech `Rings` in $85M+ for next-gen gene therapy effort

    ENDPTS

    Flagship Unveils Ampersand Biomedicines to Create Highly Effective Medicines

    BUSINESSWIRE

    Flagship fledging fetches $50M to fire drugs at specific organs

    FIERCE BIOTECH

    Investors Senda message with $123M to back mystery pipeline

    FIERCEBIOTECH

    Moderna founder launches Apriori with $50M to stay ahead of virus variants

    BIOPHARMADIVE

    Michael Severino, Joins Flagship Pioneering-Founded Tessera Therapeutics as CEO

    BUSINESSWIRE

    Flagship-backed Axcella drops PhII program as it focuses on long Covid, NASH

    ENDPTS

    Flagship-run ProFound unveils with $75M to develop protein trove

    FIERCEBIOTECH

    While down 87% YOY, Evelo gets Flagship and others to infuse new capital

    ENDPTS

    Moderna chairman Noubar Afeyan defends vetting process in wake of CFO scandal

    ENDPTS

    Flagship Pioneering unfurls cell signaling company Sonata Therapeutics

    FIERCEBIOTECH

    Novo Nordisk, Flagship Enter Deal For Cardiometabolic, Rare Disorder Treatments

    BIOSPACE

    Flagship Pioneering hires lobbyists, a first among biotech venture firms

    STATNEWS

    Flagship Pioneering Appoints Michelle C. Werner as CEO-Partner & CEO of Alltrna

    PRNEWSWIRE

    Vesalius Therapeutics launches to develop treatments for common diseases

    STATNEWS

    Ribon taps former Novartis VP Raman as CEO

    FIERCEBIOTECH

    Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform

    BUSINESSWIRE

    New biotech era: Flagship CEO, Moderna chair`s 1st annual letter

    FIERCEBIOTECH

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.